MolNFT v1 · #120606 · protein
Crystal structure of human GPX4 in complex with gxpep-2
5H5R · Phospholipid hydroperoxide glutathione peroxidase…: “Crystal structure of human GPX4 in complex with gxpep-2”. X-ray diffraction, 2 ligands (ACE, NH2). MolNFT v1 #120606 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5H5R
- Type
- protein
- Length
- 182 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Phospholipid hydroperoxide glutathione peroxidase, mitochondrial; Gxpep-2
- EC
- 1.11.1.12
- UniProt
- P36969
- Ligands
- ACE, NH2
Structure
x-ray diffraction · 2 distinct chains · 31% helix, 21% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Phospholipid hydroperoxide glutathione peroxidase, mitochondrial (EC 1.11.1.12) | protein | 169 | 33% helix, 19% strand | P36969 |
| B | Gxpep-2 | protein | 13 | 0% helix, 54% strand | — |
Ligands and binding sites
- ACE · Acetyl group · ligand · chains B
- NH2 · Amino group · ion · chains B
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Interfaces
1 interface between chains.
- A–B · 606 Ų buried · 13 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 1 covalent, 1 disulfide, 1 modified (covalent ligand, disulfide, oxidation).
Compared structures
- 5H5R · Crystal structure of human GPX4 in complex with GXpep-2 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P36969
- Elsewhere: RCSB PDB 5H5R · PDBe 5H5R · UniProt P36969
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.